Information on EC 6.3.2.19 - ubiquitin-protein ligase and Organism(s) Mus musculus and UniProt Accession Q810I2
for references in articles please use BRENDA:EC6.3.2.19
deleted. The ubiquitinylation process is now known to be performed by several enzymes in sequence, starting with EC 6.2.1.45 (ubiquitin-activating enzyme E1) and followed by several transfer reactions, including those of EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme) and EC 2.3.2.27 (RING-type E3 ubiquitin transferase)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
the ubiquitin ligase Huwe1 operates upstream of the N-Myc-DLL3-Notch pathway to control neural stem cell activity and promote neurogenesis, it is part of the Huwe1-N-myc pathway
mahogunin ring finger-1, MGRN1, is a RING domain-containing ubiquitin ligase mutated in mahoganoid, a mouse mutation causing coat color darkening, congenital heart defects, high embryonic lethality, and spongiform neurodegeneration. MGRN1 isoforms decrease MC1R and MC4R signaling to cAMP, without effect on beta2-adrenergic receptor and independently on receptor plasma membrane expression, ubiquitylation, internalization, or stability and occurred upstream of Galphas binding to/activation of adenylyl cyclase. Overexpression of Galpha5 abolishes the inhibitory effect of MGRN1
mice with a MYCBP2-deficiency in peripheral sensory neurons show prolonged thermal hyperalgesia. Loss of MYCBP2 constitutively activates p38 MAPK and increases expression of several proteins involved in receptor trafficking. Loss of MYCBP2 inhibits internalization of transient receptor potential vanilloid receptor 1 and prevents desensitization of capsaicin-induced calcium increases
selective genetic inactivation of Cbl-b E3 ligase activity (C373AKI/KI knock-in) phenocopies the T cell responses observed when total Cbl-b is ablated, resulting in T cell hyperactivation, spontaneous autoimmunity, and impaired induction of T cell anergy in vivo. Mice carrying a Cbl-b E3 ligase-defective mutation spontaneously reject tumor cells that express human papilloma virus Ags
E3 ubiquitin ligases target specific molecules for proteolytic destruction and are key regulators of immune functions. The HECT-type E3 ligase AIP2 positively regulates T-cell activation, and AIP2 regulates activation-induced T-cell death by suppressing EGR2-mediated FasL expression via the ubiquitin pathway
E6-AP, a HECT domain family ubiquitin ligase implicated in Angelman syndrome, interacts with the substrate binding domain of Hsp70/Hsc70 chaperones and promotes the degradation of chaperone bound substrates
the ubiquitin ligase Huwe1 operates upstream of the N-Myc-DLL3-Notch pathway to control neural stem cell activity and promote neurogenesis. It acts as tumor suppressor gene
Fbxo45 regulates neurotransmission at mature neurons. Fbxo45 induces the degradation of the synaptic vesicle-priming factor Munc13-1. Fbxo45 plays an important role in the regulation of neurotransmission by modulating Munc13-1 at the synapse
MYCBP2 regulates internalization of transient receptor potential vanilloid receptor 1 in peripheral sensory neurons as well as duration of thermal hyperalgesia through p38 MAPK. MYCBP2 negatively controls neuronal growth
the catalytic function of the E3 ligase Cbl-b is essential for negative regulation of T cells in vivo. Cbl-b E3 ligase activity is required for in vivo T cell tolerance